A brand new research led by the Keck Faculty of Drugs of University of Southern California (USC) reveals that older adults with elevated ranges of brain-clogging plaques, but normal cognition, experience quicker mental decline, suggestive of Alzheimer’s disease. The research revealed in The Journal of the American Medical Affiliation on June 13 introduced the earliest precursor—the toxic and sticky protein as a part of the disease, before symptoms arise.
Alzheimer’s brain: Neuron with amyloid plaques. Credit: Juan Gaertner/Shutterstock.com
All researchers see amyloid plaques as a danger issue for Alzheimer’s. Nevertheless, this research looked at 10 years of knowledge from the Alzheimer’s Illness Neuroimaging Initiative—an exploration of the biomarkers that signify Alzheimer’s.
“To have the best influence on the disease, we have to intervene towards amyloid, the essential molecular cause, as early as potential,” stated Paul Aisen, senior writer of the research and director of the USC Alzheimer’s Therapeutic Research Institute (ATRI) on the Keck Faculty of Drugs. “This research is a big step toward the concept elevated amyloid levels are an early stage of Alzheimer’s, an applicable stage for anti-amyloid therapy.”
The asymptomatic stage, the incubation interval with elevated amyloid plaques, can last longer than the dementia stage.
Other articles you might like;
- Colour-changing tattoo ink could help people with diabetes
- Scientists reveal THIS technique can make you lose 2.5st in four months – without dieting
- ‘Alexa, what’s my blood sugar level and how much insulin should I take?’
- The Truth Behind Common Apple Cider Vinegar Uses You've Likely Heard Before
- Eating red onions ‘can prevent cancer’ and could protect against diabetes and heart disease